For research use only. Not for use in diagnostic procedures.
BioPharmaView™ software uses predefined N-glycan structures, or software users have the option to build their own custom modifications. Typically, the Ludger N-glycan product names (e.g., A1, A2, A1F) are used. Focusing on the number of sialic acid residues present in each modification, this nomenclature system is limited and is only able to describe a few simple glycans.
A custom modification created in BioPharmaView software can be given any name, but it needs to be unique. (The creation of custom modifications is described under the topic Add a User-Defined Modification in the BioPharmaView software Help module.) Once a custom modification is created, it remains available for other projects or experiments that are processed at a later date.
The linked document describes the different naming conventions for N-glycan structures (https://www.ludger.com/docs/info-guides/ludger-igg-glycan-names.pdf).